Holdings
iShares U.S. Pharmaceuticals ETF
As of Jun 30, 2026, iShares U.S. Pharmaceuticals ETF reported 56 positions worth US$1.14B. Largest: Johnson & Johnson, Eli Lilly And Company and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Johnson & Johnson | 1.01M | US$255M | +63,332 | Jun 30, 2026 |
| Eli Lilly And Company | 211K | US$253M | −17,965 | Jun 30, 2026 |
| Merck & Company, Inc. | 403K | US$51.8M | +8,711 | Jun 30, 2026 |
| Bristol-myers Squibb Company | 863K | US$49.7M | +99,239 | Jun 30, 2026 |
| Royalty Pharma Plc | 880K | US$49.3M | −101K | Jun 30, 2026 |
| Viatris Inc. | 3.03M | US$48M | −193K | Jun 30, 2026 |
| Pfizer, Inc. | 1.87M | US$45.1M | +196K | Jun 30, 2026 |
| Zoetis Inc. | 590K | US$42.4M | +208K | Jun 30, 2026 |
| Jazz Pharmaceuticals Plc | 163K | US$39.3M | −6,815 | Jun 30, 2026 |
| Elanco Animal Health Incorporated | 1.3M | US$31.9M | −91,039 | Jun 30, 2026 |